(Q49726263)

22 February 2018

title

Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy. (English)

1 reference

22 February 2018

2

Orit Jacobson

1 reference

22 February 2018

4

Dale O Kiesewetter

1 reference

22 February 2018

9

Xiaoyuan Chen

1 reference

22 February 2018

Rui Tian

1

1 reference

22 February 2018

Gang Niu

3

1 reference

22 February 2018

Zhantong Wang

5

1 reference

22 February 2018

Guizhi Zhu

6

1 reference

22 February 2018

Ying Ma

7

1 reference

22 February 2018

Gang Liu

8

1 reference

22 February 2018

publication date

1 January 2018

1 reference

22 February 2018

published in

Theranostics

1 reference

22 February 2018

volume

8

1 reference

22 February 2018

issue

3

1 reference

22 February 2018

page(s)

735-745

1 reference

22 February 2018

Radionuclide Therapy for Neuroendocrine Tumors

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Somatostatin Analog Therapy in Small Cell Lung Cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

A simple practice guide for dose conversion between animals and human

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Peptide receptor radionuclide therapy for advanced neuroendocrine tumors

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

A review of the use of somatostatin analogs in oncology

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Gastroenteropancreatic neuroendocrine tumours

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Somatostatin analogs for cancer treatment and diagnosis: an overview

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

The somatostatin receptor family.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Somatostatin receptors in human renal cell carcinomas

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5771089

Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors

14 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29344302

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of conjugates of bovine serum albumin with poly(alkylene oxide)s for solubilization of riboflavin ester

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29344302

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7150/THNO.23491

1 reference

22 February 2018

PMC publication ID

5771089

1 reference

22 February 2018

PubMed publication ID

29344302

1 reference

22 February 2018